PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
6461667-1	1982	H (beta 1H) controls the C3b amplification loop by its ability to displace Bb from the alternative pathway convertase, C3b,Bb, and acts as a cofactor with I (C3b inactivator) to produce inactive C3b.	boeravinone B	75-77	complement factor H	Homo sapiens	3-10	
11694537-9	2002	Mutations at the C3b.Bb interface interfere with the normal dissociation of C3b from Bb, whether it is spontaneous or promoted by DAF, CR1, or factor H.	boeravinone B	21-23	complement factor H	Homo sapiens	143-151	
11694537-9	2002	Mutations at the C3b.Bb interface interfere with the normal dissociation of C3b from Bb, whether it is spontaneous or promoted by DAF, CR1, or factor H.	boeravinone B	85-87	complement factor H	Homo sapiens	143-151	
2964038-3	1988	However, the activity of the serum control protein of the alternative complement pathway, factor H, in controlling streptococcus-bound C3b and C3b,Bb was 6-8 times stronger on M+ organisms than on M- organisms.	boeravinone B	147-149	complement factor H	Homo sapiens	90-98	
390986-6	1979	Sialic acid residues on C3b-bearing particles augment binding of beta 1H to favor competition with B, inactivation of C3b and decay-dissociation of C3b, Bb.	boeravinone B	153-155	complement factor H	Homo sapiens	65-72	
6459381-4	1982	C3b bound to cells that had been treated with virus, and P-stabilized amplification convertase sites P,C3b,Bb formed on these cells, exhibited increased resistance to the action of the regulatory proteins beta-1H and C3b Ina compared with C3b and P,C3b,Bb on untreated, nonactivating cells.	boeravinone B	107-109	complement factor H	Homo sapiens	205-212	
77846-5	1978	Cell-bound beta1H was also dissociated by the action of B (or Bb).	boeravinone B	62-64	complement factor H	Homo sapiens	11-17	
77846-7	1978	The C3b site-bearing cell could bind beta1H on the C3c region of C3b molecules facilitating the C3bINA action on C3b, and beta1H shared the same binding site with B (or Bb) inhibiting the generation of the alternative pathway convertases competitively.	boeravinone B	169-171	complement factor H	Homo sapiens	122-128	
30248148-5	2018	RESULTS: In adjusted analyses, HF1, HF2 and CKD273 (p <= 0.024) were higher in BB users than non-users with a similar trend for ACSP75 (p = 0.06).	boeravinone B	82-84	complement factor H	Homo sapiens	31-34	
30248148-5	2018	RESULTS: In adjusted analyses, HF1, HF2 and CKD273 (p <= 0.024) were higher in BB users than non-users with a similar trend for ACSP75 (p = 0.06).	boeravinone B	82-84	complement factor H	Homo sapiens	36-39	
30248148-6	2018	Patients started on BB within 1 year after HTx and non-users had similar HF1 and HF2 levels (p >= 0.098), whereas starting BB later was associated with higher HF1 and HF2 compared with non-users (p <= 0.014).	boeravinone B	20-22	complement factor H	Homo sapiens	73-76	
30248148-6	2018	Patients started on BB within 1 year after HTx and non-users had similar HF1 and HF2 levels (p >= 0.098), whereas starting BB later was associated with higher HF1 and HF2 compared with non-users (p <= 0.014).	boeravinone B	20-22	complement factor H	Homo sapiens	81-84	
30248148-6	2018	Patients started on BB within 1 year after HTx and non-users had similar HF1 and HF2 levels (p >= 0.098), whereas starting BB later was associated with higher HF1 and HF2 compared with non-users (p <= 0.014).	boeravinone B	126-128	complement factor H	Homo sapiens	162-165	
30248148-6	2018	Patients started on BB within 1 year after HTx and non-users had similar HF1 and HF2 levels (p >= 0.098), whereas starting BB later was associated with higher HF1 and HF2 compared with non-users (p <= 0.014).	boeravinone B	126-128	complement factor H	Homo sapiens	170-173	
29174517-7	2018	Positive associations were also observed for C3a (beta=0.64 [0.31; 0.97]), FD (beta=1.00 [0.59; 1.42]), FH (beta=1.17 [0.82; 1.53]), and properdin (beta=0.60 [0.28; 0.92]), but not for Bb, C5a or sC5b-9.	boeravinone B	185-187	complement factor H	Homo sapiens	104-106